Sharda Cropchem Ltd
Sharda Cropchem Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
1 of 3 strong
The short version
The company maintains FY27 revenue growth guidance of 10%-15%. The company expects sustained revenue growth of 10%-15% for FY27.
From Sharda Cropchem Ltd's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- The company maintains FY27 revenue growth guidance of 10%-15%.
- Volume growth for the year is expected around 10%, with recovery anticipated particularly in Europe after a slower Q1.
- Europe is expected to rebound strongly in the next three quarters, recovering from weather-related volume decline.
- NAFTA and LATAM regions have shown strong volume growth in Q1 and are expected to maintain momentum.
- Future growth is expected from both volume increases and new product additions with higher realizations.
2 more points from Sharda Cropchem Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Sharda Cropchem Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Sharda Cropchem continues to invest significantly in intangible CAPEX, mainly product registrations, with annual investment around Rs. 450-500 crores.
- The high CAPEX of Rs. 273 crores in Q1 FY27 included some unusual data compensation spend but the company has not revised its full-year CAPEX guidance.
- Full-year CAPEX guidance remains around Rs. 500 crores despite higher Q1 spend.
- The company emphasizes that registration activities are full of uncertainties with timelines and costs unpredictable.
- Investments in new product registrations are ongoing and crucial for long-term growth and margin improvement.
2 more points from Sharda Cropchem Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Sharda Cropchem Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Sharda Cropchem Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Sharda Cropchem Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹319 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sharda Cropchem Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Advance Agrolife Ltd (Q1 FY27)
Q1 FY27 revenue from operations: ₹3,304 million, a 96% year-on-year (YoY) increase (Page 23, 25, 22). Key concall takeaways from Advance Agrolife Ltd's Q1 FY27…
- Bhagiradha Chemicals & Industries Ltd (Q1 FY27)
195.0 crore . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Sumitomo Chemical India Ltd (Q1 FY27)
1,063.3 crore, a 1% year-on-year (YoY) increase from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q1 FY27 earnings call — and how it ranks…
- Indogulf Cropsciences Ltd (Q1 FY27)
1800+ crores within 2-3 years. Key concall takeaways from Indogulf Cropsciences Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
Arthneeti Pro · Annual
Sharda Cropchem Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Sharda Cropchem Ltd Q1 FY27 results?
The company maintains FY27 revenue growth guidance of 10%-15%. The company expects sustained revenue growth of 10%-15% for FY27.
What is Sharda Cropchem Ltd share price analysis?
Sharda Cropchem Ltd currently shows a below-average growth signal. The stock trades at a P/E of 10.4 with a market cap of ₹6,545 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sharda Cropchem Ltd planning capital expenditure?
Sharda Cropchem continues to invest significantly in intangible CAPEX, mainly product registrations, with annual investment around Rs.
Keep Sharda Cropchem Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.